While universal health coverage (UHC) offers a powerful goal for a nation, all countries-irrespective of income are struggling with achieving or sustaining UHC. France is a high-income country where HC is in effect universal. Health-related costs are covered by a mix of mandatory social health...

This primer aims to provide IMF macroeconomists with the essential information they need in situations where they must address issues concerning health sector policy and when they have significant macroeconomic implications. Such issues can also affect equity and growth and are fundamental to...

Poverty risk is most marked for children, displaced persons and returnees, unemployed, and people with low education. Basic goals of the macroeconomic framework of the mid-term development strategy of Bosnia and Herzegovina are to reduce the overall public expenditures, lower the public debt,...

This primer aims to provide IMF macroeconomists with the essential information they need to address issues concerning health sector policy, particularly when they have significant macroeconomic implications. Such issues can also affect equity and growth and are fundamental to any strategy of...

Objectives: This study examines the organisational structure of pharmacoeconomics departments in major pharmaceutical and biotechnology companies, the impediments to optimal use of pharmacoeconomic evaluations by companies and the integration of pharmacoeconomic analysis with research and...

Objetivo: Estimar la costo-efectividad del trasplante alogénico con progenitores hematopoyéticos no emparentados compatibles, comparado con ciclos de quimioterapia de consolidación, en pacientes diagnosticados con LMA de alto riesgo. Metodología: Se construyó un árbol de decisión en el...

Objetivo: Estimar la costo efectividad del trasplante alogénico con progenitores hematopoyéticos de donante idéntico emparentado, comparado con ciclos de quimioterapia de consolidación, en pacientes diagnosticados con leucemia mieloide aguda (LMA) estratificados en riesgo alto o...

Objetivos: Estimar la costo efectividad de las pruebas para estratificación del riesgo comparadas con no hacerlas, en pacientes diagnosticados con leucemia mieloide aguda (LMA). Métodos: Se construyó un árbol de decisión con desenlace en años de vida ganados. Los costos se incluyeron desde...

ObjetivoEvaluar la costo efectividad de PCR comparado con citometría de flujo para detectar EMR al final de la inducción en pacientes menores de 18 años con leucemia linfoide aguda (LLA).MétodosSe construyó un árbol de decisión en TreeAge® para casos correctamente identificados...